文献速递类风湿关节炎

类风湿关节炎缓解或低疾病活动度患者成功停用生物制剂及靶向合成DMARDs的预测因素:系统文献综述

Predictors of successful discontinuation of biologic and targeted synthetic DMARDs in patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

成功停药的预测因素包括低疾病活动度、较好躯体功能、RF或ACPA低水平/阴性、CRP或ESR低水平、较短病程及超声低疾病活动信号;仅1项高风险偏倚研究涉及tsDMARD停药。

要点

  • 低疾病活动度是成功停用bDMARD最常见的预测因素(13项研究)。
  • RF或ACPA低水平/阴性、CRP或ESR低水平、较短病程及超声低活动信号亦与成功停药相关。
  • tsDMARD停药预测因素证据仅来自1项高偏倚风险研究。

核心结论

  • 识别出多个成功停用bDMARD的预测因素,虽研究异质性大,但可辅助临床决策。

主要发现

  • 成功停用b/tsDMARD的预测因素包括:低疾病活动度(13项研究)、较好躯体功能(6项)、RF低水平或阴性(5项)、ACPA低水平或阴性(3项)、CRP低水平(3项)、ESR低水平(3项)、较短病程(3项)、超声低疾病活动信号(3项)。
  • 仅1项高偏倚风险研究涉及tsDMARD停药。

关键数值与推荐

  • 成功停用b/tsDMARD的预测因素研究数:低疾病活动度13项,较好躯体功能6项,RF低水平或阴性5项,ACPA低水平或阴性3项,CRP低水平3项,ESR低水平3项,较短病程3项,超声低疾病活动信号3项。

临床怎么用

  • 对考虑停用bDMARD的RA患者,可综合评估疾病活动度、躯体功能、RF/ACPA、CRP/ESR、病程及超声活动信号以辅助决策。

局限性

  • 纳入研究异质性大;tsDMARD停药预测因素证据仅来自1项高偏倚风险研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To systematically review possible predictors of successful discontinuation of biologic or targeted synthetic DMARDs (b/tsDMARDs) in RA patients in remission or low disease activity. METHODS: MEDLINE database and Cochrane Library were scanned for studies that discontinued b/tsDMARDs in remission/low disease activity and searched for predictors of successful discontinuation. Additionally, EULAR and ACR meeting abstracts were hand searched. RESULTS: Thirty-four studies with a total of 5724 patients were included. Predictors of successful b/tsDMARD discontinuation were (number of studies): low disease activity (n = 13), better physical function (n = 6), low or absence of rheumatoid factor (n = 5) or ACPA (n = 3), low levels of CRP (n = 3) or ESR (n = 3), shorter disease duration (n = 3), low signals of disease activity by ultrasound (n = 3). Only one study with high risk of bias was identified on tsDMARD discontinuation. CONCLUSION: Several predictors of successful bDMARD discontinuation were identified. Although studies are heterogeneous, these predictors may inform clinical decision making in patients who are considered for a potential bDMARD discontinuation.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Schlager L, Loiskandl M, Aletaha D, et al. Predictors of successful discontinuation of biologic and targeted synthetic DMARDs in patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review. Rheumatology (Oxford). 2020. PMID: 31325305. doi:10.1093/rheumatology/kez278

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。